Autoimmune Encephalitis and Paraneoplastic Syndrome: Current Knowledge and Updates delivers a comprehensive exploration of immune-mediated disorders affecting the nervous system, with an emphasis on autoimmune encephalitis. The book systematically discusses the definition and classification of these conditions, delves into their underlying mechanisms, and presents the latest treatment strategies. Through the integration of case studies and clinical examples, it offers practical insights for both clinicians and researchers. Designed with clear flow charts and organized chapters, this resource is invaluable for navigating the complexities of diagnosis and management within neuroimmunology, making it an indispensable guide for medical professionals.
The book also addresses crucial aspects such as demographic variations, tumor associations, and patient outcomes. It equips readers with evidence-based guidelines for treatment, while also highlighting recent advancements in research, and its inclusion of real-world examples and visual aids enhances understanding and application in clinical settings.
1. Definition, classification, and epidemiology of autoimmune
encephalitis
2. General approach to diagnosis and work up for autoimmune encephalitis
3. Pathogenesis, pathophysiology and disease mechanism of neuronal antibody
mediated encephalitis
4. Classification of Autoimmune Encephalitis
5. Recent Treatment Guidelines and approach toward autoimmune encephalitis
6. Newer autoimmune syndromes and updates on clinical trials
7. Neuroimaging and biomarkers in autoimmune CNS disorders
Dr. Shitiz K. Sriwastava, MD, is an Assistant Professor in the Department of Neurology with the Division of Multiple Sclerosis and Neuroimmunology at the University of Texas Health Science Center Houston (UTHealth). He is a board-certified neurologist specialized in multiple sclerosis (MS). During his fellowship training and residency at Wayne State, he performed clinical research on MS and related autoimmune disorders of the central nervous system. He has had many years of experience in MS related clinical trials as a fellow or co-investigator. Dr. Sriwastava has a keen interest in identifying prognostic markers to predict the initiation and progression of MS especially early neurogenerative changes and also DTI studies in MS. He is currently a member of the American Academy of Neurology. His clinical, basic and translational studies in neuroimmunologic diseases have resulted in 50 peer reviewed papers and reports, published abstracts from national and international meetings.
